CG Oncology Inc. (CGON) shares tumbled 5.6% to $73.36 as of September 24, 2026, a significant decline from the prior close of $77.74. BestStocks flagged the session as a major change for CGON. The move is tied to price move down. Below, we break down what changed for CGON, why it matters for investors, how the stock reacted, and the catalysts on the calendar.
What happened
CGON fell 5.6% to $73.36
CGON tumbled 5.6% in its latest session, moving from $77.74 to $73.36.
Material / EarningsLow confidence
Rel. volume
0.9×
Below Avg
Vs peers
—
No comparable peers
Market cap
$6.5B
NASDAQ
Analyst target
$87
+18.9% vs price
Price chart
Aug 24 – Sep 23
E earnings
F filing
A analyst
V/N other
click a marker to highlight
Change events — click to jump to details
What it means for CG Oncology Inc. investors
For CG Oncology Inc. investors, the recent signals add up to a bearish shift. On the constructive side: CG Oncology Inc. (CGON) moved +5.04% from $69.80 to $73.32 on 2026-07-09. Weighing against that: Material negative event; Sharp 5.6% decline — elevated risk. Wall Street's consensus price target sits at $87.20, implying +18.9% upside from $73.36. BestStocks rates the overall signal quality low (57/100). With earnings roughly 50 days out, the next report is the most likely near-term test of the move.
CGON price reaction
CGON last traded at $73.36, down $4.38 (-5.63%) from the previous close of $77.74. The session traded on 0.9× average volume (below avg), so participation was unremarkable. Over the past month the stock has ranged between $71.96 and $79.01, and it currently sits about 20% of the way up that band.
Bullish and bearish analyst opinions on CG Oncology Inc. (CGON)
The consensus analyst price target on CG Oncology Inc. (CGON) is $87.20, 18.9% above the recent $73.36. Over the past 90 days analysts logged 0 upgrades, 3 maintains, and 0 downgrades. Here is how the bullish and bearish cases on CGON line up.
▲ The bullish case
+Wall Street's consensus price target of $87.20 implies +18.9% upside from $73.36.
+The Street's most bullish target is $100.00 (+36.3%).
+CG Oncology Inc. (CGON) moved +5.04% from $69.80 to $73.32 on 2026-07-09.
▼ The bearish case
−Material negative event.
−Sharp 5.6% decline — elevated risk.
Bull vs bear balanceBearish Shift
BearishNeutralBullish
Weighing both sides, BestStocks' composite read of recent signals is bearish, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.
Analyst price targets and ratings are FMP consensus figures as of Sep 23, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.
CG Oncology Inc. (CGON) moved +2.72% from $76.17 to $78.25 on 2026-09-21. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. Volume remained near its 5-day average.
Material / Earnings2026-09-02-1.7%
CG Oncology Inc. (CGON) moved -2.93% from $76.84 to $74.59 on 2026-09-02. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. Volume remained near its 5-day average, indicating no unusual trading activity.
CG Oncology declined 6.10% to $74.19 intraday, driven by routine profit-taking and sector-wide volatility in clinical-stage oncology names following the company's Q2 earnings report in early August, which posted a wider-than-expected per-share loss. Volume of 266,619 shares traded 330 minutes into the session was 0.41x the historical average for that time—below typical levels—suggesting modest institutional participation in the pullback.
Material / Earnings2026-08-20-3.8%
CG Oncology Inc. (CGON) moved -2.63% from $79.71 to $77.61 on August 20, 2026. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. Volume remained near its 5-day average, suggesting the move lacked institutional conviction.
Material / Earnings2026-08-19+5.8%
CG Oncology Inc. (CGON) moved +3.58% from $77.89 to $80.68 on 2026-08-19. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. The move coincided with CGON reaching a new 30-day high on volume near its 5-day average.
Material / Earnings2026-08-17+2.8%
CG Oncology Inc. (CGON) moved +3.64% from $74.40 to $77.11 on 2026-08-17, reaching a new 30-day high. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found.
Material / Earnings2026-08-13-3.0%
CG Oncology Inc. (CGON) moved -3.29% from $77.25 to $74.71 on 2026-08-13. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. Volume remained near its 5-day average, indicating routine trading activity.
Material / Earnings2026-08-06+3.4%
CG Oncology Inc. (CGON) reported EPS of −$0.90 vs. consensus estimate of −$0.66, missing expectations by 35.5% for Q2 FY2026 on August 6, 2026.
Upcoming catalysts & outlook
Next earnings
2026-11-13 (est.)
in 50 days
Earnings Release
2026-11-13
High impact
Thesis shift
Bearish Shift
bearish signal
Risk level
Low
from change events
Frequently asked questions about CGON
Why did CG Oncology Inc. (CGON) stock move?
CGON tumbled 5.6% to $73.36. No single company-specific catalyst was confirmed during the move window, and it looks technical.
How much did CGON stock fall?
CGON lost 5.63% ($4.38) versus the prior close of $77.74, last trading at $73.36 on 0.9× average volume.
When is CG Oncology Inc.'s next earnings date?
CGON's next earnings report is estimated for 2026-11-13 — about 50 days away.
What is the analyst price target for CGON?
The consensus analyst price target for CGON is $87.20, about 18.9% above the current $73.36. Over the past 90 days, analysts recorded 0 upgrades, 3 maintains, and 0 downgrades.
How BestStocks tracks CGON
This page is generated automatically by BestStocks' change-detection system after price move down was detected and verified against independent data sources. It draws on 20 tracked change events for CGON, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of September 24, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.
